{"product_id":"hpp-5013","title":"Rabbit Anti-Helicobacter Pylori Vac (Toxin) Antigen, IgG Fraction, Polyclonal","description":"\u003cp\u003eRabbit polyclonal antibody raised against highly purified H. pylori Vac antigen. It has been purified using G protein.\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eStorage:\u003c\/strong\u003e Store at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStability:\u003c\/strong\u003e At least 1 year at -20°C.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eBiological activity:\u003c\/strong\u003e This antibody has been used for Western Blot analysis at a 1\/100-1\/2000 dilution.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eFormulation:\u003c\/strong\u003e Solution at 0.70 mg\/mL in 0.1M Tris-HCl (pH 7.5)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c!-- AB_PUBLISHED_USE_START --\u003e\n\u003csection class=\"ab-published-use ab-published-use-complete\"\u003e\n\u003ch3 id=\"ab-published-use-hpp-5013\"\u003ePublications using Austral Biologicals HPP-5013-9\u003c\/h3\u003e\n\u003cp\u003eThe following scientific publications report use of Austral Biologicals HPP-5013-9:\u003c\/p\u003e\n\u003col class=\"ab-publication-list ab-publication-list-complete\"\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1186\/s12929-024-01031-8\" rel=\"noopener\" target=\"_blank\"\u003eMembrane lipid remodeling eradicates Helicobacter pylori by manipulating the cholesteryl 6'-acylglucoside biosynthesis\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eOng et al., J Biomed Sci 31(1):44 (2024).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1016\/j.micpath.2021.105353\" rel=\"noopener\" target=\"_blank\"\u003eInfection with a hypervirulent strain of Helicobacter pylori primes gastric cells toward intestinal transdifferentiation\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eSaberi et al., Microbial Pathogenesis 162:105353 (2022).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.3390\/ijms22083942\" rel=\"noopener\" target=\"_blank\"\u003eOuter Membrane Vesicle Production by Helicobacter pylori Represents an Approach for the Delivery of Virulence Factors CagA, VacA and UreA into Human Gastric Adenocarcinoma (AGS) Cells\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eChew et al., Int J Mol Sci 22(8):3942 (2021).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1038\/s41598-017-15204-z\" rel=\"noopener\" target=\"_blank\"\u003eNatural history of Helicobacter pylori VacA toxin in human gastric epithelium in vivo: vacuoles and beyond\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eNecchi et al., Sci Rep 7(1):14526 (2017).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1007\/s00795-013-0068-2\" rel=\"noopener\" target=\"_blank\"\u003eA new type of intrabacterial nanotransportation system for VacA in Helicobacter pylori\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eWu et al., Medical Molecular Morphology 47(4):224-232 (2014).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1177\/039463201302600308\" rel=\"noopener\" target=\"_blank\"\u003eHelicobacter pylori HP(2-20) induces eosinophil activation and accumulation in superficial gastric mucosa and stimulates VEGF-alpha and TGF-beta release by interacting with formyl-peptide receptors\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003ePrevete et al., International Journal of Immunopathology and Pharmacology 26(3):647-662 (2013).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.3324\/haematol.2011.048462\" rel=\"noopener\" target=\"_blank\"\u003eUbiquitin-proteasome-rich cytoplasmic structures in neutrophils of patients with Shwachman-Diamond syndrome\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eNecchi et al., Haematologica 97(7):1057-1063 (2012).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.pone.0021317\" rel=\"noopener\" target=\"_blank\"\u003eProteasome particle-rich structures are widely present in human epithelial neoplasms: correlative light, confocal and electron microscopy study\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eNecchi et al., PLoS One 6(6):e21317 (2011).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.ppat.1002050\" rel=\"noopener\" target=\"_blank\"\u003eHelicobacter pylori perturbs iron trafficking in the epithelium to grow on the cell surface\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eTan et al., PLoS Pathog 7(5):e1002050 (2011).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1093\/infdis\/jiq090\" rel=\"noopener\" target=\"_blank\"\u003eEffects of blood group antigen-binding adhesin expression during Helicobacter pylori infection of Mongolian gerbils\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eOhno et al., J Infect Dis 203(5):726-735 (2011).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1371\/journal.pone.0009716\" rel=\"noopener\" target=\"_blank\"\u003eIn vivo accumulation of Helicobacter pylori products, NOD1, ubiquitinated proteins and proteasome in a novel cytoplasmic structure\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eNecchi et al., PLOS ONE 5(3):e9716 (2010).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doaj.org\/article\/53dc8d5ea4c14fff9aa933a0fe3cbbc8\" rel=\"noopener\" target=\"_blank\"\u003eCharacterization of the Vacuolating Cytotoxin in Helicobacter pylori Strains Isolated from Iran\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eDouraghi et al., Cell Journal (Yakhteh Medical Journal) 12(1):1-6 (2010).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/jb.187.13.4463-4469.2005\" rel=\"noopener\" target=\"_blank\"\u003eStable accumulation of sigma54 in Helicobacter pylori requires the novel protein HP0958\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003ePereira et al., J Bacteriol 187(13):4463-4469 (2005).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003ca href=\"https:\/\/doi.org\/10.1128\/iai.68.5.2863-2869.2000\" rel=\"noopener\" target=\"_blank\"\u003eRole of activated protein C in Helicobacter pylori-associated gastritis\u003c\/a\u003e. \u003cspan class=\"ab-publication-citation\"\u003eOka et al., Infect Immun 68(5):2863-2869 (2000).\u003c\/span\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/section\u003e\n\u003c!-- AB_PUBLISHED_USE_END --\u003e\n\u003cp class=\"ab-datasheet-link\"\u003e\u003ca href=\"https:\/\/helix-chartreuse-ypja.squarespace.com\/s\/Austral_Biologicals_HPP-5013_Datasheet.pdf\" rel=\"noopener\" target=\"_blank\"\u003e\u003cstrong\u003eDownload technical datasheet (PDF)\u003c\/strong\u003e\u003c\/a\u003e\u003c\/p\u003e","brand":"Austral Biologicals","offers":[{"title":"1mg","offer_id":52517546852654,"sku":"HPP-5013-9","price":425.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1006\/2846\/3918\/files\/austral-biologicals-hpp-5013-1mg.png?v=1788008414","url":"https:\/\/www.australbiologicals.com\/products\/hpp-5013","provider":"Austral Biologicals","version":"1.0","type":"link"}